The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
Open accessAbstract
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 231,840 new cases of invasive breast cancer and 40,290 breast cancer deaths are expected to occur among US women in 2015. Breast cancer incidence rates increased among non‐Hispanic black (black) and Asian/Pacific Islander women and were stable among non‐Hispanic white (white), Hispanic, and American Indian/Alaska Native women from 2008 to 2012. Although white women have historically had higher incidence rates than black women, in 2012, the rates converged. Notably, during 2008 through 2012, incidence rates were significantly higher in black women compared with white women in 7 states, primarily located in the South. From 1989 to 2012, breast cancer death rates decreased by 36%, which translates to 249,000 breast cancer deaths averted in the United States over this period. This decrease in death rates was evident in all racial/ethnic groups except American Indians/Alaska Natives. However, the mortality disparity between black and white women nationwide has continued to widen; and, by 2012, death rates were 42% higher in black women than in white women. During 2003 through 2012, breast cancer death rates declined for white women in all 50 states; but, for black women, declines occurred in 27 of 30 states that had sufficient data to analyze trends. In 3 states (Mississippi, Oklahoma, and Wisconsin), breast cancer death rates in black women were stable during 2003 through 2012. Widening racial disparities in breast cancer mortality are likely to continue, at least in the short term, in view of the increasing trends in breast cancer incidence rates in black women. CA Cancer J Clin 2016;31–42. © 2015 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Self-citationAmerican Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Self-citationEffect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Breast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Self-citationMa, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Self-citationSummary health statistics for U.S. adults: national health interview survey, 2012.
Blackwell, D. L., Lucas, J. W., & Clarke, T. C. (2014) · PubMed · Cited by 1,884
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Self-citationBlows, F. M., Driver, K. E., Schmidt, M. K., Broeks, A., van Leeuwen, F. E., Wesseling, J., Cheang, M. C., Gelmon, K., Nielsen, T. O., Blomqvist, C., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000279 · Cited by 1,116
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Epidemiology of basal-like breast cancer
Millikan, R. C., Newman, B., Tse, C.-K., Moorman, P. G., Conway, K., Smith, L. V., Labbok, M. H., Geradts, J., Bensen, J. T., Jackson, S., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9632-6 · Cited by 886
Martin, J. A., Hamilton, B. E., Osterman, M. J. K., Curtin, S. C., & Matthews, T. J. (2015) · PubMed · Cited by 719
Yang, X. R., Chang-Claude, J., Goode, E. L., Couch, F. J., Nevanlinna, H., Milne, R. L., Gaudet, M., Schmidt, M. K., Broeks, A., Cox, A., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq526 · Cited by 691
Ethnicity and Breast Cancer: Factors Influencing Differences in Incidence and Outcome
Chlebowski, R. T., Chen, Z., Anderson, G. L., Rohan, T., Aragaki, A., Lane, D., Dolan, N. C., Paskett, E. D., McTiernan, A., Hubbell, F. A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji064 · Cited by 656
Iqbal, J., Ginsburg, O., Rochon, P. A., Sun, P., & Narod, S. A. (2015) · JAMA · doi:10.1001/jama.2014.17322 · Cited by 614
Cancer Incidence and Mortality Trends Among Whites in the United States, 1947–84
(1987) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/79.4.701 · Cited by 450
Daly, B., & Olopade, O. I. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21271 · Cited by 327
Silber, J. H., Rosenbaum, P. R., Clark, A. S., Giantonio, B. J., Ross, R. N., Teng, Y., Wang, M., Niknam, B. A., Ludwig, J. M., Wang, W., et al. (2013) · JAMA · doi:10.1001/jama.2013.8272 · Cited by 305
Delays in Breast Cancer Diagnosis and Treatment by Racial/Ethnic Group
Gorin, S. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2244 · Cited by 294
Disparities in breast cancer characteristics and outcomes by race/ethnicity
Ooi, S. L., Martinez, M. E., & Li, C. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1191-6 · Cited by 292
Established breast cancer risk factors and risk of intrinsic tumor subtypes
Barnard, M. E., Boeke, C. E., & Tamimi, R. M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.002 · Cited by 278
How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M., & Sherman, M. E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju165 · Cited by 265
Systems Biology and Genomics of Breast Cancer
Perou, C. M., & Borresen-Dale, A.-L. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003293 · Cited by 241
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer
Tamimi, R. M., Colditz, G. A., Hazra, A., Baer, H. J., Hankinson, S. E., Rosner, B., Marotti, J., Connolly, J. L., Schnitt, S. J., & Collins, L. C. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1702-0 · Cited by 238
Harper, S., Lynch, J., Meersman, S. C., Breen, N., Davis, W. W., & Reichman, M. C. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0679 · Cited by 221
Palmer, J. R., Viscidi, E., Troester, M. A., Hong, C.-C., Schedin, P., Bethea, T. N., Bandera, E. V., Borges, V., McKinnon, C., Haiman, C. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju237 · Cited by 203
Curtis, E., Quale, C., Haggstrom, D., & Smith‐Bindman, R. (2008) · Cancer · doi:10.1002/cncr.23131 · Cited by 197
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
Cheang, M. C. U., Martin, M., Nielsen, T. O., Prat, A., Voduc, D., Rodriguez-Lescure, A., Ruiz, A., Chia, S., Shepherd, L., Ruiz-Borrego, M., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0372 · Cited by 194
Gaudet, M. M., Press, M. F., Haile, R. W., Lynch, C. F., Glaser, S. L., Schildkraut, J., Gammon, M. D., Douglas Thompson, W., & Bernstein, J. L. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1616-x · Cited by 190
Fruit and vegetable intake and risk of breast cancer by hormone receptor status
Jung, S., Spiegelman, D., Baglietto, L., Bernstein, L., Boggs, D. A., van den Brandt, P. A., Buring, J. E., Cerhan, J. R., Gaudet, M. M., Giles, G. G., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs635 · Cited by 183 · cited 1×
“There is growing evidence that high levels of fruit and vegetable consumption may reduce the risk of HR-negative breast cancer.(65) These findings are supported by studies linking lower breast cancer risk to higher blood levels of carotenoids.”
ResultInsurance status and stage of cancer at diagnosis among women with breast cancer
Halpern, M. T., Bian, J., Ward, E. M., Schrag, N. M., & Chen, A. Y. (2007) · Cancer · doi:10.1002/cncr.22786 · Cited by 182
Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities
Dieci, M. V., Orvieto, E., Dominici, M., Conte, P., & Guarneri, V. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0108 · Cited by 172
Socioeconomic status and survival after an invasive breast cancer diagnosis
Sprague, B. L., Trentham‐Dietz, A., Gangnon, R. E., Ramchandani, R., Hampton, J. M., Robert, S. A., Remington, P. L., & Newcomb, P. A. (2011) · Cancer · doi:10.1002/cncr.25589 · Cited by 162
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
DeSantis, C., Howlader, N., Cronin, K. A., & Jemal, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0061 · Cited by 159
Self-citationUpdate on mammography trends: Comparisons of rates in 2000, 2005, and 2008
Breen, N., Gentleman, J. F., & Schiller, J. S. (2011) · Cancer · doi:10.1002/cncr.25679 · Cited by 155
Bandera, E. V., Chandran, U., Hong, C., Troester, M. A., Bethea, T. N., Adams-Campbell, L. L., Haiman, C. A., Park, S., Olshan, A. F., Ambrosone, C. B., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3353-z · Cited by 151
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Tao, L., Gomez, S. L., Keegan, T. H. M., Kurian, A. W., & Clarke, C. A. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0243 · Cited by 138
Danforth, D. N. (2013) · Breast Cancer Research · doi:10.1186/bcr3429 · Cited by 137
Li, C. I., Beaber, E. F., Tang, M. T. C., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2365-1 · Cited by 136
Bias Associated With Self-Report of Prior Screening Mammography
Cronin, K. A., Miglioretti, D. L., Krapcho, M. F., Yu, B., Geller, B. M., Carney, P. A., Onega, T., Feuer, E. J., Breen, N., & Ballard-Barbash, R. R. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0020 · Cited by 136
Canfell, K., Banks, E., Moa, A., & Beral, V. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01821.x · Cited by 135
Phipps, A. I., Malone, K. E., Porter, P. L., Daling, J. R., & Li, C. I. (2008) · Cancer · doi:10.1002/cncr.23786 · Cited by 128
Dızdar, Ö., Aksoy, S., & Altundağ, K. (2009) · Cancer · doi:10.1002/cncr.24187 · Cited by 124
Plasma carotenoids and risk of breast cancer over 20 y of follow-up
Eliassen, A. H., Liao, X., ROSNER, B. A., Tamimi, R. M., Tworoger, S. S., & Hankinson, S. E. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105080 · Cited by 123
Faupel‐Badger, J. M., Arcaro, K. F., Balkam, J. J., Eliassen, A. H., Hassiotou, F., Lebrilla, C. B., Michels, K. B., Palmer, J. R., Schedin, P. S., Stuebe, A. M., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs505 · Cited by 115
Trends in breast cancer incidence and mortality in the United States: implications for prevention
Toriola, A. T., & Colditz, G. A. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2500-7 · Cited by 113
Ambrosone, C. B., Zirpoli, G., Ruszczyk, M. U., Shankar, J., Hong, C., McIlwain, D., Roberts, M., Yao, S., McCann, S. E., Ciupak, G. L., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0323-9 · Cited by 102
Zbuk, K. M., & Anand, S. S. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.083774 · Cited by 99
Parkin, D. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.01.016 · Cited by 92
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77 · cited 1×
“This trend in part may reflect the rising rates of obesity in black women, which increased from 39% in 1999 through 2002, to 49% in 2003 through 2006, to 58% in 2009 through 2012.(21) Obesity is a risk factor for postmenopausal breast cancer, and a recent study reported that a high recent body mass index was associate…”
BackgroundSelf-citationEffects of payer status on breast cancer survival: a retrospective study
Shi, R., Taylor, H., McLarty, J., Liu, L., Mills, G., & Burton, G. (2015) · BMC Cancer · doi:10.1186/s12885-015-1228-7 · Cited by 60
The impact of changes in hormone therapy on breast cancer incidence in the US population
Coombs, N. J., Cronin, K. A., Taylor, R. J., Freedman, A. N., & Boyages, J. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9437-5 · Cited by 54
Validating Self-Reported Mammography Use in Vulnerable Communities: Findings and Recommendations
Allgood, K. L., Rauscher, G. H., Whitman, S., Vasquez-Jones, G., & Shah, A. M. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1253 · Cited by 43
Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort
Wang, Y., Gapstur, S. M., Gaudet, M. M., Furtado, J. D., Campos, H., & McCullough, M. L. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0614-4 · Cited by 37
Njai, R. S., Siegel, P. Z., Miller, J. W., & Liao, Y. (2011) · PubMed Central · Cited by 28
Accuracy of Diagnostic Mammography at Facilities Serving Vulnerable Women
Goldman, L., Walker, R. L., Miglioretti, D. L., Smith‐Bindman, R., & Kerlikowske, K. M. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181f380e0 · Cited by 19
Antoine, C., Ameye, L., Paesmans, M., & Rozenberg, S. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.04.013 · Cited by 11
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814213 · Cited by 874
Health and Racial Disparity in Breast Cancer
Yedjou, C. G., Sims, J. N., Miele, L., Noubissi, F., Lowe, L., Fonseca, D. D., Alo, R. A., Payton, M., & Tchounwou, P. B. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_3 · Cited by 509
A systematic survey of computer-aided diagnosis in medicine: Past and present developments
Yanase, J., & Triantaphyllou, E. (2019) · Expert Systems with Applications · doi:10.1016/j.eswa.2019.112821 · Cited by 303
Metadata
- Authors
- DeSantis, C. E., Fedewa, S. A., Goding Sauer, A., Kramer, J. L., Smith, R. A., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2015-10-29
- Volume
- 66
- Issue
- 1
- Pages
- 31-42
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W1830454849
- Cited by
- 1,252
- References
- 61
- FWCI
- 60.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.